Composition:
Each tablet of Lapatinib 250 mg contains 250 mg of Lapatinib as the active ingredient.
Description:
HERTAB (Lapatinib) is an oral therapy indicated for the treatment of postmenopausal women with HER2-positive advanced breast cancer patients whose disease has progressed after taking Trastuzumab therapy. Lapatinib is used in combination with other medication Capecitabine or Letrozole, which together, inhibit the growth of cancer cells in patients.
Lapatinib 250 mg is mainly prescribed for the treatment of:
Share your experience with our medical product. Write a review!
17 Nov 2025
Early Detection Saves Lives: A Parent’s Guide to Preventive Care for Childhood Asthma
When we talk about childhood asthma, it’s not an abstract worry-it’s a very real condition that affects millions of kids worldwide.
17 Nov 2025
The Role of Lifestyle Modifications in Chronic Disease Prevention
Chronic diseases-like type 2 diabetes, heart disease, hypertension, and certain cancers-are no longer just problems for “other people.”
29 Sep 2025
Gut Health and Immunity: Why a Healthy Digestive System is Your First Line of Defense
When most people think of the immune system, they imagine white blood cells, vaccines, or medicines that protect the body from infections.
29 Sep 2025
The Future of Pain Relief: From Traditional Balms to Next-Gen Transdermal Patches
Pain is one of the most common reasons people seek medical attention, whether it’s muscle pain after a long day, joint pain due to arthritis, or chronic conditions that affect daily living.
